400 related articles for article (PubMed ID: 21720501)
41. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
[TBL] [Abstract][Full Text] [Related]
42. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
43. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
44. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
Wu J; Zhang J; Deng C; Meng F; Zhong Z
Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
[TBL] [Abstract][Full Text] [Related]
45. Current advances in research and clinical applications of PLGA-based nanotechnology.
Lü JM; Wang X; Marin-Muller C; Wang H; Lin PH; Yao Q; Chen C
Expert Rev Mol Diagn; 2009 May; 9(4):325-41. PubMed ID: 19435455
[TBL] [Abstract][Full Text] [Related]
46. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
47. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
48. Novel Simvastatin-Loaded Nanoparticles Based on Cholic Acid-Core Star-Shaped PLGA for Breast Cancer Treatment.
Wu Y; Wang Z; Liu G; Zeng X; Wang X; Gao Y; Jiang L; Shi X; Tao W; Huang L; Mei L
J Biomed Nanotechnol; 2015 Jul; 11(7):1247-60. PubMed ID: 26307847
[TBL] [Abstract][Full Text] [Related]
49. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
51. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
Narvekar M; Xue HY; Wong HL
Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
[TBL] [Abstract][Full Text] [Related]
52. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer.
Gupta P; Singh M; Kumar R; Belz J; Shanker R; Dwivedi PD; Sridhar S; Singh SP
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):67-69. PubMed ID: 29593398
[TBL] [Abstract][Full Text] [Related]
54. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
[TBL] [Abstract][Full Text] [Related]
55. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
[TBL] [Abstract][Full Text] [Related]
56. Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells.
Das J; Das S; Samadder A; Bhadra K; Khuda-Bukhsh AR
Eur J Pharm Sci; 2012 Sep; 47(2):313-24. PubMed ID: 22771545
[TBL] [Abstract][Full Text] [Related]
57. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Pandita D; Kumar S; Lather V
Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
[TBL] [Abstract][Full Text] [Related]
58. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and characterization of PLGA nanoparticles.
Astete CE; Sabliov CM
J Biomater Sci Polym Ed; 2006; 17(3):247-89. PubMed ID: 16689015
[TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]